FDA Drug Recalls

Recalls / Class II

Class IID-1317-2020

Product

Carbamazepine Tablets, USP 200 mg, packaged in a 500-count bottle, Rx only, Manufactured by: Torrent Pharmaceuticals Ltd, Bharuch 392130, India; Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-268-05

Brand name
Carbamazepine
Generic name
Carbamazepine
Active ingredient
Carbamazepine
Route
Oral
NDCs
13668-268, 13668-271
FDA application
ANDA077272
Affected lot / code info
Lot #: 4FF4F001, Exp 1/2023

Why it was recalled

Failed Dissolution Specifications

Recalling firm

Firm
Torrent Pharma Inc.
Manufacturer
Torrent Pharmaceuticals Limited
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
150 Allen Rd Ste 102, N/A, Basking Ridge, New Jersey 07920-3856

Distribution

Quantity
6228 Bottles
Distribution pattern
USA Nationwide and Puerto Rico

Timeline

Recall initiated
2020-05-11
FDA classified
2020-06-18
Posted by FDA
2020-06-10
Terminated
2022-08-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1317-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Carbamazepine · FDA Drug Recalls